Carbapenem Resistance Conferred by OXA-48 in K2-ST86 Hypervirulent Klebsiella pneumoniae, France

Emerg Infect Dis. 2020 Jul;26(7):1529-1533. doi: 10.3201/eid2607.191490.

Abstract

We recovered 2 carbapenem-resistant K2-ST86 hypermucoviscous Klebsiella pneumoniae isolates from patients in France. The isolates had genetic attributes of hypervirulent K. pneumoniae but differed in ability to cause mouse lethality. Convergence of hypervirulent K. pneumoniae toward resistance could cause a health crisis because such strains could be responsible for severe and untreatable infections.

Keywords: France; Klebsiella pneumoniae; OXA-48; antimicrobial resistance; bacteria; hypervirulent; next-generation sequencing; β-lactamase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Carbapenems / pharmacology
  • France / epidemiology
  • Humans
  • Klebsiella Infections* / drug therapy
  • Klebsiella Infections* / epidemiology
  • Klebsiella pneumoniae* / genetics
  • Mice
  • Virulence

Substances

  • Anti-Bacterial Agents
  • Carbapenems